Related Experiment Video
Updated: Aug 3, 2026
07:28
An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
Published on: April 15, 2015
Genome polymorphism and alcoholism
J Thome1, J C Gewirtz, H G Weijers
1Laboratory of Biochemistry, Central Institute of Mental Health, Mannheim, Germany. thome@as200.zi-mannheim.de
Pharmacogenomics
|March 22, 2001
Summary
Genetic factors influence alcoholism risk and treatment response. Research into gene variants may help identify subtypes and develop novel gene therapies for addiction.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Alcoholism is a complex psychiatric disorder influenced by multiple genetic and environmental factors.
- Specific gene variants (e.g., dopamine receptors, serotonin transporters) are linked to addiction susceptibility.
- Individual genetic makeup may influence personality traits, treatment response, and secondary disease severity in alcoholism.
Purpose of the Study:
- To explore the role of genetic variations in alcoholism.
- To investigate the potential of genetic research in identifying alcoholism subtypes.
- To examine the implications of genetic polymorphisms for treatment strategies and disease outcomes.
Main Methods:
- Review of genetic research on alcoholism.
- Analysis of gene variants associated with addictive behaviors.
- Examination of genetic influences on personality and treatment response.
Main Results:
- Gene variants are identified as risk or protective factors for alcoholism.
- Genetic polymorphisms influence predisposition, personality traits, and treatment response.
- Genetic factors may affect the severity of alcohol-related secondary diseases.
Conclusions:
- Genetic research is crucial for understanding alcoholism heterogeneity and developing targeted therapies.
- Gene therapy approaches are under investigation in preclinical models.
- Further research is needed to translate genetic findings into clinical practice for alcoholism treatment.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...